Edwards Lifesciences target price raised to $97 from $85 by Canaccord Genuity
EW•Canaccord Genuity raised its target price for Edwards Lifesciences to $97 from $85.
Related News
Milford sees US policy gridlock supporting stocks after Democratic midterm sweep
SPY•
Wayfair Inc.: RBC raises target price to $128 from $96
W•
JPMorgan cuts Circle Internet Group price target to $100 from $110
CRCL•
Myriad Genetics target price raised to $8 from $5 by Leerink Partners
MYGN•
RBC raises Zimmer Biomet target price to $125 from $110
ZBH•